Qiancao (Rubia spp.) - a comprehensive metabolomics analysis of the five core species

茜草(Rubia spp.)——五种核心物种的综合代谢组学分析

阅读:1

Abstract

INTRODUCTION: Qiancao comprises five closely related species: Rubia cordifolia L., Rubia yunnanensis Diels., Rubia wallichiana Decne., Rubia schumanniana Pritz., and Rubia magna P. G. Xiao. Due to their similar morphological characteristics, alternative species are frequently substituted for R. cordifolia L. in traditional medicine. However, the latest National Pharmacopoeia of China only exclusively recognizes R. cordifolia L. as the official medicinal source. The metabolic differences among these species remain poorly characterized, largely owing to the absence of systematic metabolomic studies. METHODS: This study employed a metabolomics approach to investigate the five Rubia species. The selected species were analyzed using an untargeted metabolomic approach based on ultrahigh-performance liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS). Subsequently, multivariate statistical analysis combined with bioinformatics was applied to identify differential metabolites and elucidate their associated metabolic pathways. RESULTS AND DISCUSSION: This metabolomics analysis identified a total of 1,440 metabolites. Comparative analyses revealed significant differences in the metabolic profiles among the five species. Specifically, we detected 237, 217, 448, and 226 differentially accumulated metabolites when comparing R. cordifolia L. with R. magna P. G. Xiao, R. cordifolia L. with R. schumanniana Pritz., R. cordifolia L. with R. yunnanensis Diels., and R. cordifolia L. with R. wallichiana Decne., respectively. KEGG pathway analysis demonstrated substantial involvement of these metabolites in three key pathways: amino acid metabolism, riboflavin metabolism, and terpenoid biosynthesis, with particular emphasis on specific metabolites within these pathways. These findings provide a foundation for future research focused on species identification, quality control, biosynthetic pathway investigation, and bioactivity assessment of Qiancao, thereby advancing the understanding of its clinical applications in traditional Chinese medicine.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。